Diabetes-related mortality among Mexican Americans, Puerto Ricans, and Cuban Americans in the United States

Abstract

Our analyses of these data demonstrate that diabetes-related mortality differed among Mexican Americans, Puerto Ricans and Cuban Americans more than 35 years of age in the United States in 1996 and 1997. Socioeconomic factors such as low educational attainment and low income may be factors that contributed to the disparities in these mortality rates for different subgroups. Further research is needed to update these findings and to investigate explanatory risk factors. Diversity among Hispanic subgroups has persisted in recent years and should be considered when health policies and services targeted at these populations are developed.

Hypertension and Diabetes Prevalence Among U.S. Hispanics by Country of Origin: The National Health Interview Survey 2000-2005

“…Studies evaluating disease prevalence in other Hispanic subgroups have provided conflicting results, partly due to differences in analytical approach and study design. Also, most studies have focused on the historically prominent groups (MexicanAmericans, Puerto Ricans, Cubans), leaving out those of Caribbean, Central, or South American descent [18][19][20][21][22][23] .…”

Age-Adjusted Diabetes Mortality Rates Vary in Local Communities in a Metropolitan Area: Racial and Spatial Disparities and Correlates

“…Efforts to understand differences in diabetes morbidity and mortality have revealed variation by gender (7)(8)(9)(10)(11)(12), age (8,11,13,14), socioeconomic status (15)(16)(17)(18), and race/ethnicity (7)(8)(9)(11)(12)(13)16,19,20). Nationally, for example, the highest diabetes mortality rates are found among African Americans (39.6), followed by Hispanics/Latinos (27.1) and then whites (18.2) (6).…”

Diabetes Control Among Hispanics in the Action to Control Cardiovascular Risk in Diabetes Trial

“…1 This heterogeneity influences disease risk, diagnosis and management 2,3 and accumulating evidence shows differences among Hispanics in the rising prevalence and severity of cardiometabolic diseases including diabetes. [4][5][6][7][8] To date, there is no comparative prospective data on diabetes control among Hispanics. Of the four major prospective trials of type 2 diabetes, [9][10][11][12][13] only the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, and the Veteran Affairs Diabetes Trial (VADT) included Hispanic participants.…”